Carmel Capital Partners’s GoodRx Holdings GDRX Stock Holding History

Carmel Capital Partners’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-33,174	Closed	-$187K	–	351
2023 Q3	$187K	Sell	33,174 -191	-0.6%	-$1.27K	0.08%	152
2023 Q2	$184K	Buy	33,365 +2,242	+7%	+$12.1K	0.09%	125
2023 Q1	$195K	Buy	31,123 +4,068	+15%	+$22.7K	0.12%	132
2022 Q4	$126K	Sell	27,055 -10,193	-27%	-$50.2K	0.09%	126
2022 Q3	$174K	Buy	37,248 +2,372	+7%	+$15K	0.17%	111
2022 Q2	$206K	Sell	34,876 -2,176	-6%	-$24.2K	0.19%	105
2022 Q1	$716K	Buy	37,052 +7,735	+26%	+$177K	0.6%	51
2021 Q4	$958K	Buy	+29,317	New	+$1.18M	0.72%	41

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carmel Capital Partners's GDRX Position: Q4 2023 in Review

Carmel Capital Partners sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 33,174 shares — an estimated $187K sold.

Carmel Capital Partners first reported a position in GDRX in Q4 2021 and held it in 8 quarters. The position peaked at $958K in Q4 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

Carmel Capital Partners reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
Carmel Capital Partners sold 33,174 GoodRx Holdings shares in Q4 2023, an estimated $187K.
Carmel Capital Partners first reported a position in GoodRx Holdings in Q4 2021 and held it in 8 quarters.
Carmel Capital Partners's GoodRx Holdings position peaked at $958K in Q4 2021.
143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.